Pharma Focus Asia

Pharma Focus Asia Pharma Focus Asia - Magazine for Pharma Industry Leaders
https://www.linkedin.com/company/pharmafocusasia/ Ltd.. Pharma Focus Asia offers . . .

Pharma Focus Asia is a half yearly publication from Ochre Media Pvt. It is the leading pharma title in print and digital versions serving the information needs of key executives from the worldโ€™s leading pharmaceutical companies. Pharma Focus Asia covers important issues and trends shaping the future of the pharma industry across Asia and rest of the world. Dedicated, reliable and accurate coverage of the industryโ€™s progress and
Incisive analysis to help its readers make informed decisions to stay ahead of the competition. The magazine provides cutting-edge and futuristic content on the pharma industry. The issues are broadly categorized into various sections:

Strategy
Research and Development
Manufacturing
Clinical Trials
Information Technology


The one-stop pharma destination www.pharmafocusasia.com features complete content from the Pharma Focus Asia magazine. Also find the latest pharma news, press releases, pharma industry reports, interviews, trends and pharma events updated on a daily basis. The magazine is supplemented by the monthly e-Newsletter: Verticaltalk Pharma. The readership

The magazineโ€™s readership includes the top C-level executives, senior industry executives, and key decision makers from the pharma industry in charge of spending. With a special focus on Asia, Pharma Focus Asia reaches out to the key industry leaders across Asia, Europe and the Americas.

๐Œ๐ข๐ฅ๐ค-๐๐ž๐ซ๐ข๐ฏ๐ž๐ ๐ž๐ฑ๐จ๐ฌ๐จ๐ฆ๐ž๐ฌ are becoming one of the most exciting developments in biopharma. These tiny natural carriers can s...
03/12/2025

๐Œ๐ข๐ฅ๐ค-๐๐ž๐ซ๐ข๐ฏ๐ž๐ ๐ž๐ฑ๐จ๐ฌ๐จ๐ฆ๐ž๐ฌ are becoming one of the most exciting developments in biopharma. These tiny natural carriers can safely deliver therapeutic agents, enhance oral bioavailability, and support immune healthโ€”all while offering scalability and cost-effectiveness.

From arthritis relief to ๐œ๐š๐ง๐œ๐ž๐ซ ๐๐ซ๐ฎ๐  ๐๐ž๐ฅ๐ข๐ฏ๐ž๐ซ๐ฒ and ๐ฌ๐ข๐‘๐๐€ ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ฒ, the possibilities are expanding fast. As research accelerates, the industry is now focusing on scalable manufacturing and safety benchmarking for future breakthrough therapies.

Want to stay updated with cutting-edge pharma trends?

๐•๐ข๐ฌ๐ข๐ญ ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž ๐Ÿ๐จ๐ซ ๐ฆ๐จ๐ซ๐ž ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ: https://www.pharmafocusasia.com/articles/incipient-biopharmaceutical-claims-of-milk-derived-exosomes

Pharma is rapidly evolvingโ€”and greener, safer solvents are shaping the future! ๐ŸŒฑ๐ƒ๐ž๐ž๐ฉ ๐„๐ฎ๐ญ๐ž๐œ๐ญ๐ข๐œ ๐’๐จ๐ฅ๐ฏ๐ž๐ง๐ญ๐ฌ (๐ƒ๐„๐’๐ฌ) are emergi...
02/12/2025

Pharma is rapidly evolvingโ€”and greener, safer solvents are shaping the future! ๐ŸŒฑ
๐ƒ๐ž๐ž๐ฉ ๐„๐ฎ๐ญ๐ž๐œ๐ญ๐ข๐œ ๐’๐จ๐ฅ๐ฏ๐ž๐ง๐ญ๐ฌ (๐ƒ๐„๐’๐ฌ) are emerging as a game-changer for crystallisation, extraction, purification, and more, reducing environmental impact while improving solubility performance for complex APIs.

By moving away from VOCs, the industry is taking a major step toward worker safety, sustainability, and high-efficiency drug development.

Want to stay ahead of this industrial shift?

๐•๐ข๐ฌ๐ข๐ญ ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž ๐Ÿ๐จ๐ซ ๐ญ๐ก๐ž ๐Ÿ๐ฎ๐ฅ๐ฅ ๐š๐ซ๐ญ๐ข๐œ๐ฅ๐ž ๐š๐ง๐ ๐ž๐ฑ๐ฉ๐ž๐ซ๐ญ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐จ๐ง ๐ง๐ž๐จ๐ญ๐ž๐ซ๐ข๐œ ๐ฌ๐จ๐ฅ๐ฏ๐ž๐ง๐ญ๐ฌ ๐ข๐ง ๐ฉ๐ก๐š๐ซ๐ฆ๐š.
https://www.pharmafocusasia.com/articles/neoteric-solvents-a-paradigm-shift-in-pharmaceutical-industrial-processes

๐€ ๐›๐ซ๐ž๐š๐ค๐ญ๐ก๐ซ๐จ๐ฎ๐ ๐ก ๐ข๐ง ๐ญ๐ก๐ž ๐Ÿ๐ข๐ ๐ก๐ญ ๐š๐ ๐š๐ข๐ง๐ฌ๐ญ ๐๐ซ๐ฎ๐ -๐ซ๐ž๐ฌ๐ข๐ฌ๐ญ๐š๐ง๐ญ ๐ญ๐ฎ๐›๐ž๐ซ๐œ๐ฎ๐ฅ๐จ๐ฌ๐ข๐ฌ! ๐ŸŒOur research team is investigating triazole-based benz...
01/12/2025

๐€ ๐›๐ซ๐ž๐š๐ค๐ญ๐ก๐ซ๐จ๐ฎ๐ ๐ก ๐ข๐ง ๐ญ๐ก๐ž ๐Ÿ๐ข๐ ๐ก๐ญ ๐š๐ ๐š๐ข๐ง๐ฌ๐ญ ๐๐ซ๐ฎ๐ -๐ซ๐ž๐ฌ๐ข๐ฌ๐ญ๐š๐ง๐ญ ๐ญ๐ฎ๐›๐ž๐ซ๐œ๐ฎ๐ฅ๐จ๐ฌ๐ข๐ฌ! ๐ŸŒ

Our research team is investigating triazole-based benzimidazole derivatives using computational drug design tools to identify safer and more effective TB inhibitors. By analyzing how molecules behave inside the body and how they interact with the bacterial target, we aim to accelerate the development of future-ready TB treatments.

Letโ€™s work together to support innovation in global health and infectious disease research.

๐Ÿ‘‰ ๐•๐ข๐ฌ๐ข๐ญ ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž ๐ญ๐จ ๐ฌ๐ญ๐š๐ฒ ๐ฎ๐ฉ๐๐š๐ญ๐ž๐ ๐š๐ง๐ ๐ฌ๐ฎ๐ฉ๐ฉ๐จ๐ซ๐ญ ๐จ๐ฎ๐ซ ๐ข๐ง๐ข๐ญ๐ข๐š๐ญ๐ข๐ฏ๐ž!
https://www.pharmafocusasia.com/articles/computational-approach-towards-designing-potent-inhibitors-for-tuberculosis

The newest Pharma Focus Asia newsletter is hereโ€”packed with content the pharma community loves! From industry ๐€๐‘๐“๐ˆ๐‚๐‹๐„๐’ ๐š...
28/11/2025

The newest Pharma Focus Asia newsletter is hereโ€”packed with content the pharma community loves! From industry ๐€๐‘๐“๐ˆ๐‚๐‹๐„๐’ ๐š๐ง๐ ๐ˆ๐๐“๐„๐‘๐•๐ˆ๐„๐–๐’ ๐ญ๐จ ๐‘๐„๐’๐„๐€๐‘๐‚๐‡ ๐ˆ๐๐’๐ˆ๐†๐‡๐“๐’, ๐“๐„๐‚๐‡๐๐Ž ๐“๐‘๐„๐๐ƒ๐’, ๐„๐•๐„๐๐“๐’, ๐๐Ž๐ƒ๐‚๐€๐’๐“๐’, and moreโ€”itโ€™s your one-stop source to stay informed and inspired.

Whether youโ€™re in research, manufacturing, regulatory, or healthcare strategyโ€”thereโ€™s something valuable for every pharma professional.

https://industry.pharmafocusasia.com/e-newsletters/1764238680-Nov-25.html
๐Ÿ’ก Stay updated. Stay connected.

๐Ÿ‘‰ ๐’๐ฎ๐›๐ฌ๐œ๐ซ๐ข๐›๐ž ๐ง๐จ๐ฐ ๐š๐ง๐ ๐ฌ๐ก๐š๐ซ๐ž ๐ข๐ญ ๐ฐ๐ข๐ญ๐ก ๐ฒ๐จ๐ฎ๐ซ ๐ง๐ž๐ญ๐ฐ๐จ๐ซ๐ค: https://www.pharmafocusasia.com/subscribe

The biologics sector is entering a new eraโ€”and pharma leaders across Asia-Pacific are shaping its momentum!In her insigh...
28/11/2025

The biologics sector is entering a new eraโ€”and pharma leaders across Asia-Pacific are shaping its momentum!

In her insightful article, ๐’๐ฎ๐ซ๐›๐ก๐ข ๐†๐ฎ๐ฉ๐ญ๐š, ๐๐ซ๐ข๐ง๐œ๐ข๐ฉ๐š๐ฅ ๐š๐ญ ๐…๐ซ๐จ๐ฌ๐ญ & ๐’๐ฎ๐ฅ๐ฅ๐ข๐ฏ๐š๐ง, explains how scaling biologics relies on six major building blocks: strong manufacturing, smarter regulation, skilled talent, innovation clusters, sustainable funding, and collaborative partnerships.

From major ADC and monoclonal antibody facilities to regulatory reforms and biotech workforce programs, the future of biopharma is being built right nowโ€”and itโ€™s driven by community-wide collaboration.

๐Ÿ’ก Want to stay updated on the fastest-growing areas of biologics and what they mean for pharma professionals?

๐Ÿ‘‰ ๐•๐ข๐ฌ๐ข๐ญ ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž ๐Ÿ๐จ๐ซ ๐ฆ๐จ๐ซ๐ž ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐ฎ๐ฉ๐๐š๐ญ๐ž๐ฌ ๐š๐ง๐ ๐จ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ:
https://www.pharmafocusasia.com/articles/biologics-at-scale

๐‚๐š๐ง๐œ๐ž๐ซ ๐ญ๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ is evolvingโ€”and natural nanomaterials like Cellulose Nanocrystals (CNCs) are playing an increasingly im...
27/11/2025

๐‚๐š๐ง๐œ๐ž๐ซ ๐ญ๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ is evolvingโ€”and natural nanomaterials like Cellulose Nanocrystals (CNCs) are playing an increasingly important role. CNCs show strong potential for delivering anticancer drugs more safely and more effectively, thanks to their biocompatibility, unique structure, and ability to target tumor environments.

From controlled drug release to photothermal/photodynamic therapy and reduced toxicity to healthy cells, CNC-based delivery systems are opening doors to smarter and less invasive cancer care.

Whether you're a pharma professional, researcher, biotech innovator, or healthcare stakeholder, this breakthrough is worth your attention.

๐ŸŒ ๐‹๐ž๐š๐ซ๐ง ๐ก๐จ๐ฐ ๐‚๐๐‚๐ฌ ๐š๐ซ๐ž ๐ซ๐ž๐ฌ๐ก๐š๐ฉ๐ข๐ง๐  ๐ญ๐ก๐ž ๐Ÿ๐ฎ๐ญ๐ฎ๐ซ๐ž ๐จ๐Ÿ ๐จ๐ง๐œ๐จ๐ฅ๐จ๐ ๐ฒ ๐ก๐ž๐ซ๐ž:
https://www.pharmafocusasia.com/articles/how-ready-are-cellulose-nanocrystals-in-delivery-of-anticanceragents

๐€๐ง๐ญ๐ข๐ฆ๐ข๐œ๐ซ๐จ๐›๐ข๐š๐ฅ ๐ซ๐ž๐ฌ๐ข๐ฌ๐ญ๐š๐ง๐œ๐ž is already costing millions of lives each yearโ€”but thereโ€™s another lesser-known challenge worse...
25/11/2025

๐€๐ง๐ญ๐ข๐ฆ๐ข๐œ๐ซ๐จ๐›๐ข๐š๐ฅ ๐ซ๐ž๐ฌ๐ข๐ฌ๐ญ๐š๐ง๐œ๐ž is already costing millions of lives each yearโ€”but thereโ€™s another lesser-known challenge worsening the problem: antibiotic tolerance.

In a powerful expert article, ๐’๐š๐ซ๐š๐ง๐ฌ๐ก ๐‚๐ก๐š๐ฎ๐๐ก๐š๐ซ๐ฒ (๐๐ซ๐ž๐ฌ๐ข๐๐ž๐ง๐ญ, ๐†๐ฅ๐จ๐›๐š๐ฅ ๐‚๐ซ๐ข๐ญ๐ข๐œ๐š๐ฅ ๐‚๐š๐ซ๐ž, ๐•๐ž๐ง๐ฎ๐ฌ ๐‘๐ž๐ฆ๐ž๐๐ข๐ž๐ฌ ๐‹๐ญ๐. & ๐‚๐„๐Ž, ๐•๐ž๐ง๐ฎ๐ฌ ๐Œ๐ž๐๐ข๐œ๐ข๐ง๐ž ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‚๐ž๐ง๐ญ๐ซ๐ž) shares why bacteria that survive treatment without being fully eliminated are driving persistent infections and paving the way toward resistance.

๐“๐ก๐ž ๐ก๐จ๐ฉ๐ž๐Ÿ๐ฎ๐ฅ ๐ฉ๐š๐ซ๐ญ?
Unlike resistance, tolerance can be reversedโ€”meaning we still have a window to protect todayโ€™s antibiotics.

Letโ€™s bring this conversation to the forefront and build awareness in clinical practice, research, and healthcare policy.

๐‘๐ž๐š๐ ๐ญ๐ก๐ž ๐Ÿ๐ฎ๐ฅ๐ฅ ๐š๐ซ๐ญ๐ข๐œ๐ฅ๐ž ๐š๐ง๐ ๐ฃ๐จ๐ข๐ง ๐ญ๐ก๐ž ๐ฆ๐จ๐ฏ๐ž๐ฆ๐ž๐ง๐ญ ๐š๐ ๐š๐ข๐ง๐ฌ๐ญ ๐€๐Œ๐‘:
https://www.pharmafocusasia.com/articles/why-tackling-antibiotic-tolerance-is-crucial

Many promising drugs never reach their full potential because of low solubility and poor absorptionโ€”but the industry now...
24/11/2025

Many promising drugs never reach their full potential because of low solubility and poor absorptionโ€”but the industry now has a solution.

๐‹๐ข๐ฉ๐ข๐-๐๐š๐ฌ๐ž๐ ๐ƒ๐ซ๐ฎ๐  ๐ƒ๐ž๐ฅ๐ข๐ฏ๐ž๐ซ๐ฒ ๐’๐ฒ๐ฌ๐ญ๐ž๐ฆ๐ฌ (๐‹๐๐ƒ๐ƒ๐’) are transforming how BCS Class II and IV drugs are formulated. By incorporating drug molecules into lipid carriers such as nanoemulsions, liposomes, and SMEDDS, these systems help improve solubility, stability, absorption, and bioavailability.

This innovation is bringing new possibilities for effective oral formulations, especially for modern high-molecular-weight therapeutic candidates.

๐Ÿ“ Curious how LBDDS could support future drug delivery breakthroughs?

โžก๏ธ ๐•๐ข๐ฌ๐ข๐ญ ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž ๐š๐ง๐ ๐ฃ๐จ๐ข๐ง ๐ญ๐ก๐ž ๐Ÿ๐ฎ๐ญ๐ฎ๐ซ๐ž ๐จ๐Ÿ ๐ฉ๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐ญ๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ: https://www.pharmafocusasia.com/articles/lipid-based-drug-delivery-systems

Scaling ๐›๐ข๐จ๐ฌ๐ข๐ฆ๐ข๐ฅ๐š๐ซ ๐ฆ๐š๐ง๐ฎ๐Ÿ๐š๐œ๐ญ๐ฎ๐ซ๐ข๐ง๐  can feel complexโ€”but data-driven decisions can make the path clearer.At Cytiva, we anal...
24/11/2025

Scaling ๐›๐ข๐จ๐ฌ๐ข๐ฆ๐ข๐ฅ๐š๐ซ ๐ฆ๐š๐ง๐ฎ๐Ÿ๐š๐œ๐ญ๐ฎ๐ซ๐ข๐ง๐  can feel complexโ€”but data-driven decisions can make the path clearer.

At Cytiva, we analyze the economic impact of different bioprocessing systems, from single-use and stainless-steel setups to continuous manufacturing. With detailed cost projections for labor, materials, media, resin, consumables, and capital, youโ€™ll gain clarity on where efficiency and savings are possible.

Considering optimization or planning your next biosimilar project?

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐š ๐‚๐ฒ๐ญ๐ข๐ฏ๐š ๐ž๐ฑ๐ฉ๐ž๐ซ๐ญ ๐ญ๐จ๐๐š๐ฒ ๐š๐ง๐ ๐ ๐ž๐ญ ๐ ๐ฎ๐ข๐๐š๐ง๐œ๐ž ๐ญ๐š๐ข๐ฅ๐จ๐ซ๐ž๐ ๐ญ๐จ ๐ฒ๐จ๐ฎ๐ซ ๐ ๐จ๐š๐ฅ๐ฌ.
https://industry.pharmafocusasia.com/clientemailblast/1763617405-Cytiva---Biosimilars.html

The future of drug development is taking shape with ๐‡๐ฎ๐ฆ๐š๐ง-๐จ๐ง-๐š-๐‚๐ก๐ข๐ฉ ๐ญ๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒโ€” a breakthrough that blends biology, engi...
21/11/2025

The future of drug development is taking shape with ๐‡๐ฎ๐ฆ๐š๐ง-๐จ๐ง-๐š-๐‚๐ก๐ข๐ฉ ๐ญ๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒโ€” a breakthrough that blends biology, engineering, and innovation to create realistic models of how drugs interact with the human body.

These advanced platforms can simulate organ functions, test toxicity, reduce animal studies, and even support personalised medicine approaches.

For researchers, healthcare professionals, and pharma innovators, this shift represents a major step forward toward safer, faster, and more efficient therapeutics.

๐Ÿ‘‰ ๐–๐š๐ง๐ญ ๐ญ๐จ ๐ฌ๐ž๐ž ๐ก๐จ๐ฐ ๐ญ๐ก๐ข๐ฌ ๐ญ๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐ข๐ฌ ๐ข๐ฆ๐ฉ๐š๐œ๐ญ๐ข๐ง๐  ๐ฉ๐ก๐š๐ซ๐ฆ๐š ๐‘&๐ƒ? ๐•๐ข๐ฌ๐ข๐ญ ๐ฎ๐ฌ ๐ก๐ž๐ซ๐ž: https://www.pharmafocusasia.com/articles/futuristic-application-of-human-on-a-chip-technology

The pandemic revealed something powerful: when governments simplify regulatory processes, the pharma sector can respond ...
20/11/2025

The pandemic revealed something powerful: when governments simplify regulatory processes, the pharma sector can respond faster, scale better, and save more lives.

From temporary manufacturing approvals to emergency authorisations for PPE and diagnostic kits, many countries showed how quick regulatory action can support both businesses and communities. But these measures must become consistentโ€”not just crisis-driven.

A more adaptive regulatory environment means faster vaccines, reliable medical supplies, and stronger healthcare systems for everyone.

Letโ€™s work toward policies that support innovation while safeguarding public health.

๐‹๐ž๐š๐ซ๐ง ๐ก๐จ๐ฐ ๐ฌ๐ฆ๐š๐ซ๐ญ๐ž๐ซ ๐ซ๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐ฉ๐ซ๐š๐œ๐ญ๐ข๐œ๐ž๐ฌ ๐œ๐š๐ง ๐ฌ๐ญ๐ซ๐ž๐ง๐ ๐ญ๐ก๐ž๐ง ๐ญ๐ก๐ž ๐ฉ๐ก๐š๐ซ๐ฆ๐š ๐ž๐œ๐จ๐ฌ๐ฒ๐ฌ๐ญ๐ž๐ฆ:๐Ÿ‘‰ https://www.pharmafocusasia.com/articles/pharma-regulatory-bottlenecks-and-vaccination-delays

๐๐š๐ง๐จ๐ž๐ฆ๐ฎ๐ฅ๐ฌ๐ข๐จ๐ง๐ฌ are changing the game in psoriasis care by helping medications reach deeper layers of the skinโ€”where tradi...
20/11/2025

๐๐š๐ง๐จ๐ž๐ฆ๐ฎ๐ฅ๐ฌ๐ข๐จ๐ง๐ฌ are changing the game in psoriasis care by helping medications reach deeper layers of the skinโ€”where traditional creams and gels often fall short.

Their tiny droplet size and lipid-friendly nature allow better pe*******on through the rough, scaly patches seen in psoriatic skin. This means improved effectiveness, reduced irritation, and higher patient comfort. With the rising need for safer topical therapies, nanoemulsions offer a smart, science-backed way forward.

If your team is working on dermal formulations or advanced topical delivery systems, we can help accelerate your innovation pipeline.

๐•๐ข๐ฌ๐ข๐ญ ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž ๐ญ๐จ ๐œ๐จ๐ง๐ง๐ž๐œ๐ญ ๐ฐ๐ข๐ญ๐ก ๐จ๐ฎ๐ซ ๐Ÿ๐จ๐ซ๐ฆ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง ๐ž๐ฑ๐ฉ๐ž๐ซ๐ญ๐ฌ: https://www.pharmafocusasia.com/articles/nanoemulsion-a-promising-nanocarrier-for-dermal-drug-delivery-in-psoriasis

Address

111, 112 First Floor, Block 2, White House
Hyderabad
500016

Alerts

Be the first to know and let us send you an email when Pharma Focus Asia posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Pharma Focus Asia:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram